🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TCR-T cell therapy experienced a breakthrough for treating tumors in recent...
Status
Unknown
Location
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2017-03-21
Trial ID
NCT03029273
Treatments Being Tested
This pilot phase I trial studies the side effects of taking ipilimumab afte...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center
Start Date
2014-07-17
Trial ID
NCT02070406
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02
Trial ID
NCT02062359
This pilot clinical trial studies the side effects of anti-ESO (cancer/test...
Status
Terminated
Location
Albert Einstein College of Medicine
Start Date
2017-04-20
Trial ID
NCT02774291
This phase Ib trial tests the safety, side effects and best dose of anti-HL...
Status
Recruiting
Location
USC / Norris Comprehensive Cancer Center
Start Date
2024-12-17
Trial ID
NCT05989828
This phase I trial studies the side effects and the best dose of nivolumab ...
Status
Completed
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-01-03
Trial ID
NCT02775292
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-10-24
Trial ID
NCT01967823
Treatments Being Tested
Background: Autologous T cells engineered to express a T cell receptor (TC...
Status
Unknown
Location
Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University
Start Date
2015-04
Trial ID
NCT02457650
Treatments Being Tested
A Phase I/II Dose Escalation, Safety and Efficacy Study of HBI 0201-ESO TCR...
Status
Recruiting
Location
Hadassah Medical Organization
Start Date
2022-04-01
Trial ID
NCT05296564
Treatments Being Tested